Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned From a Novel Pilot Program.

Selig W, Banks I, Davis A, DeCotiis G, Hohman R, Schlager L.

Ther Innov Regul Sci. 2019 May;53(3):349-353. doi: 10.1177/2168479018790533. Epub 2018 Aug 8.

PMID:
30089395
2.

Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.

Lyons JJ, Liu Y, Ma CA, Yu X, O'Connell MP, Lawrence MG, Zhang Y, Karpe K, Zhao M, Siegel AM, Stone KD, Nelson C, Jones N, DiMaggio T, Darnell DN, Mendoza-Caamal E, Orozco L, Hughes JD, McElwee J, Hohman RJ, Frischmeyer-Guerrerio PA, Rothenberg ME, Freeman AF, Holland SM, Milner JD.

J Exp Med. 2017 Apr 3;214(4):1201. doi: 10.1084/jem.2016143503082017c. Epub 2017 Mar 13. No abstract available.

3.

ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.

Lyons JJ, Liu Y, Ma CA, Yu X, O'Connell MP, Lawrence MG, Zhang Y, Karpe K, Zhao M, Siegel AM, Stone KD, Nelson C, Jones N, DiMaggio T, Darnell DN, Mendoza-Caamal E, Orozco L, Hughes JD, McElwee J, Hohman RJ, Frischmeyer-Guerrerio PA, Rothenberg ME, Freeman AF, Holland SM, Milner JD.

J Exp Med. 2017 Mar 6;214(3):669-680. doi: 10.1084/jem.20161435. Epub 2017 Jan 26. Erratum in: J Exp Med. 2017 Apr 3;214(4):1201.

4.

Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.

Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, Ho N, Zhao M, Liu Y, O'Connell MP, Trivedi NN, Nelson C, DiMaggio T, Jones N, Matthews H, Lewis KL, Oler AJ, Carlson RJ, Arkwright PD, Hong C, Agama S, Wilson TM, Tucker S, Zhang Y, McElwee JJ, Pao M, Glover SC, Rothenberg ME, Hohman RJ, Stone KD, Caughey GH, Heller T, Metcalfe DD, Biesecker LG, Schwartz LB, Milner JD.

Nat Genet. 2016 Dec;48(12):1564-1569. doi: 10.1038/ng.3696. Epub 2016 Oct 17.

5.

Regulatory Watch: Impact of breakthrough therapy designation on cancer drug development.

Shea M, Ostermann L, Hohman R, Roberts S, Kozak M, Dull R, Allen J, Sigal E.

Nat Rev Drug Discov. 2016 Mar;15(3):152. doi: 10.1038/nrd.2016.19. No abstract available.

PMID:
26931085
6.

Regulatory decision-making meets the real world.

Hohman R, Shea M, Kozak M, Roberts S, Allen J, Sigal E.

Sci Transl Med. 2015 Nov 11;7(313):313fs46. doi: 10.1126/scitranslmed.aad5233.

PMID:
26560355
7.

Measuring degranulation of mast cells.

Hohman RJ, Dreskin SC.

Curr Protoc Immunol. 2001 May;Chapter 7:Unit 7.26. doi: 10.1002/0471142735.im0726s08.

PMID:
18432837
8.

Lon protease promotes survival of Escherichia coli during anaerobic glucose starvation.

Luo S, McNeill M, Myers TG, Hohman RJ, Levine RL.

Arch Microbiol. 2008 Feb;189(2):181-5. Epub 2007 Sep 19.

9.

Thirteenth Aspen Cancer Conference: workshop on mechanisms of toxicity and carcinogenesis.

Nesnow S, Cavanee W, Gilmer TM, Kaufman DG, Slaga TJ, Hohman R, Bishop JM, Poirier MC, Harris CC, Trump BF, Yuspa SH, Pfeifer AM, Sherman MI, Tennant R.

Mol Carcinog. 1999 Jun;25(2):99-106. No abstract available.

PMID:
10365911
10.

Detection of telomerase activity utilizing energy transfer primers: comparison with gel- and ELISA-based detection.

Uehara H, Nardone G, Nazarenko I, Hohman RJ.

Biotechniques. 1999 Mar;26(3):552-8.

11.

In situ amplification using universal energy transfer-labeled primers.

Nuovo GJ, Hohman RJ, Nardone GA, Nazarenko IA.

J Histochem Cytochem. 1999 Mar;47(3):273-80.

PMID:
10026230
12.

Aminopeptidase activity in human nasal mucosa.

Ohkubo K, Baraniuk JN, Hohman R, Merida M, Hersh LB, Kaliner MA.

J Allergy Clin Immunol. 1998 Nov;102(5):741-50.

PMID:
9819290
13.

A closed tube format for amplification and detection of DNA based on energy transfer.

Nazarenko IA, Bhatnagar SK, Hohman RJ.

Nucleic Acids Res. 1997 Jun 15;25(12):2516-21.

14.

Hydrogen peroxide effects on rat mast cell function.

Peden DB, Dailey L, DeGraff W, Mitchell JB, Lee JG, Kaliner MA, Hohman RJ.

Am J Physiol. 1994 Jul;267(1 Pt 1):L85-93.

PMID:
8048546
15.

Human nasal mucosal neutral endopeptidase (NEP): location, quantitation, and secretion.

Ohkubo K, Baraniuk JN, Hohman RJ, Kaulbach HC, Hausfeld JN, Merida M, Kaliner MA.

Am J Respir Cell Mol Biol. 1993 Nov;9(5):557-67.

PMID:
8217197
16.

Orthovanadate induces translocation of phospholipase C-gamma 1 and -gamma 2 in permeabilized mast cells.

Atkinson TP, Lee CW, Rhee SG, Hohman RJ.

J Immunol. 1993 Aug 1;151(3):1448-55.

PMID:
7687631
17.

Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.

Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA.

J Allergy Clin Immunol. 1993 Jul;92(1 Pt 1):95-104.

PMID:
7687608
18.

Distribution of secretory leukoprotease inhibitor in the human nasal airway.

Lee CH, Igarashi Y, Hohman RJ, Kaulbach H, White MV, Kaliner MA.

Am Rev Respir Dis. 1993 Mar;147(3):710-6.

PMID:
8095126
20.

Evidence for GTP-binding protein involvement in the tyrosine phosphorylation of the T cell receptor zeta chain.

Cenciarelli C, Hohman RJ, Atkinson TP, Gusovsky F, Weissman AM.

J Biol Chem. 1992 Jul 25;267(21):14527-30.

21.
22.

Immunosuppressive drugs reveal similarities between IgE receptor and T-cell receptor signaling pathways.

Hohman RJ, Hultsch T.

Transplant Proc. 1991 Dec;23(6):2907-11. Review. No abstract available.

PMID:
1836288
23.

Categorizing receptor-signaling pathways with FK 506 and rapamycin.

Hultsch T, Hohman RJ.

Transplant Proc. 1991 Dec;23(6):2961-3. Review. No abstract available.

PMID:
1721328
24.

Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription.

Hultsch T, Albers MW, Schreiber SL, Hohman RJ.

Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6229-33.

25.
27.

Uric acid is a major antioxidant in human nasal airway secretions.

Peden DB, Hohman R, Brown ME, Mason RT, Berkebile C, Fales HM, Kaliner MA.

Proc Natl Acad Sci U S A. 1990 Oct;87(19):7638-42.

28.

Cyclosporin A: new insights for cell biologists and biochemists.

Hohman RJ, Hultsch T.

New Biol. 1990 Aug;2(8):663-72. Review.

PMID:
2282365
30.

Biochemical characterization of the inhibitory effect of CsA on cytolytic T lymphocyte effector functions.

Trenn G, Taffs R, Hohman R, Kincaid R, Shevach EM, Sitkovsky M.

J Immunol. 1989 Jun 1;142(11):3796-802.

PMID:
2541201
33.

Cell proliferation after laser photocoagulation in primate retina. An autoradiographic study.

Smiddy WE, Fine SL, Quigley HA, Dunkelberger G, Hohman RM, Addicks EM.

Arch Ophthalmol. 1986 Jul;104(7):1065-9.

PMID:
3729777
35.

The receptor with high affinity for immunoglobulin E.

Metzger H, Alcaraz G, Hohman R, Kinet JP, Pribluda V, Quarto R.

Annu Rev Immunol. 1986;4:419-70. Review. No abstract available.

PMID:
3011032
36.

Optic nerve head blood flow in chronic experimental glaucoma.

Quigley HA, Hohman RM, Sanchez R, Addicks EM.

Arch Ophthalmol. 1985 Jul;103(7):956-62.

PMID:
4015488
37.

Inactivation of S-adenosyl-L-homocysteine hydrolase by cAMP results from dissociation of enzyme-bound NAD+.

Hohman RJ, Guitton MC, Veron M.

Proc Natl Acad Sci U S A. 1985 Jul;82(14):4578-81.

38.

Simulated treatment of recurrent choroidal neovascularization in primate retina. Comparative histopathologic findings.

Smiddy WE, Fine SL, Quigley HA, Hohman RM, Dunkelberger G.

Arch Ophthalmol. 1985 Mar;103(3):428-33.

PMID:
2579634
39.

Change in NAD+/NADH content of S-adenosyl-L-homocysteine hydrolase upon NAD+ reversible inactivation by cAMP and 2'-deoxyadenosine.

Hohman RJ, Véron M, Guitton MC.

Curr Top Cell Regul. 1985;26:233-45. No abstract available.

PMID:
3000695
40.
41.

Blood vessels of the glaucomatous optic disc in experimental primate and human eyes.

Quigley HA, Hohman RM, Addicks EM, Green WR.

Invest Ophthalmol Vis Sci. 1984 Aug;25(8):918-31.

PMID:
6746235
42.
43.

Comparison of krypton and argon laser photocoagulation. Results of stimulated clinical treatment of primate retina.

Smiddy WE, Fine SL, Quigley HA, Hohman RM, Addicks EA.

Arch Ophthalmol. 1984 Jul;102(7):1086-92.

PMID:
6204628
45.

Laser energy levels for trabecular meshwork damage in the primate eye.

Quigley HA, Hohman RM.

Invest Ophthalmol Vis Sci. 1983 Sep;24(9):1305-7.

PMID:
6885314
46.

Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma.

Quigley HA, Hohman RM, Addicks EM, Massof RW, Green WR.

Am J Ophthalmol. 1983 May;95(5):673-91.

PMID:
6846459
47.
49.

Quantitative study of optic nerve head capillaries in experimental optic disk pallor.

Quigley HA, Hohman RM, Addicks EM.

Am J Ophthalmol. 1982 Jun;93(6):689-99.

PMID:
7046447

Supplemental Content

Loading ...
Support Center